Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Dermal macrophages might help regrow hair.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Rats can develop an immune response to prion protein peptides, but it may cause severe skin issues in older rats.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Hair loss treatment caused more hair loss in a man.

Sorafenib may cause hair loss in a way similar to alopecia areata.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Dandruff is linked to changes in the immune system of hair follicles and skin.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Electrical epilation damages hair follicles and surrounding skin, likely preventing hair regrowth.

Skin bacteria can help wound healing by activating certain immune cells.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Hair follicles prevent NK cell attacks to avoid hair loss.

DM and AA may share a common cause.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.